Warby Parker Inc. (WRBY) FY2025 10-K Annual Report

Filed: Feb 26, 2026
Health Care
Ophthalmic GoodsSEC EDGAR

Warby Parker Inc. (WRBY) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 26, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

Warby Parker Inc. FY2025 10-K Analysis

Business Overview

  • Core direct-to-consumer eyewear brand integrating design, technology, healthcare, and social enterprise with 323 retail stores and digital commerce
  • New AI-powered intelligent eyewear partnerships with Google and Samsung announced in 2025, expanding market beyond traditional glasses
+3 more insights

Management Discussion & Analysis

  • Revenue $871.9M in 2025, up 13% YoY from $771.3M in 2024
  • Gross margin slightly declined to 54.0% in 2025 from 55.3% in 2024
+3 more insights

Risk Factors

  • Regulatory/legal risk: Costs impacted by evolving international trade policies and tariffs, with proactive supplier diversification outside China to manage volatility
  • Geopolitical/macroeconomic risk: Trade environment and inflation pressures in 2025 increased cost of goods sold 16.5% to $401.3M, reducing gross margin 130 bps to 54.0%
+3 more insights

Warby Parker Inc. FY2025 Key Financial Metrics
XBRL

Revenue

$872M

+13.0% YoY

Net Income

$2M

+108.0% YoY

Gross Margin

54.0%

-137bp YoY

Operating Margin

-0.6%

+329bp YoY

Net Margin

0.2%

+283bp YoY

ROE

0.4%

+644bp YoY

Total Assets

$721M

+6.6% YoY

EPS (Diluted)

$0.01

+105.9% YoY

Operating Cash Flow

$111M

+12.2% YoY

Source: XBRL data from Warby Parker Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Warby Parker Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.